drugset / Trial / NCT00746798
Safety and Immunogenicity Study of ChimeriVax West Nile Vaccine in Healthy Adults
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to determine if ChimeriVax West Nile vaccine is safe and effective in preventing West Nile disease in adults over 50 years of age.
Timeline
- Start
- 2008-10
- Primary completion
- 2009-06
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ChimeriVax-WN02 | Vaccine | 4000 unknown | Subcutaneous |
| Subject | ChimeriVax-WN02 | Vaccine | 40000 unknown | Subcutaneous |
| Subject | ChimeriVax-WN02 | Vaccine | 400000 unknown | Subcutaneous |